drugset / Trial / NCT03163420

Diclofenac Potassium on IANB Efficacy in Symptomatic Irreversible Pulpitis

NCT03163420

Phase 2/3 Unknown 68 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The aim of this clinical trial is to evaluate the effect of pre-operative administration of diclofenac potassium on the efficacy of inferior alveolar nerve block on using 2% mepivacaine anaesthetic agent in patients with symptomatic irreversible pulpitis.

Timeline

Start
2016-07
Primary completion
2017-07
Completion
2017-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 50 mg Oral

Indications